Your browser doesn't support javascript.
loading
The selection of variable regions affects effector mechanisms of IgA antibodies against CD20.
Evers, Mitchell; Rösner, Thies; Dünkel, Anna; Jansen, J H Marco; Baumann, Niklas; Ten Broeke, Toine; Nederend, Maaike; Eichholz, Klara; Klausz, Katja; Reiding, Karli; Schewe, Denis M; Kellner, Christian; Peipp, Matthias; Leusen, Jeanette H W; Valerius, Thomas.
Affiliation
  • Evers M; Center for Translational Immunology, University Medical Center, Utrecht, The Netherlands.
  • Rösner T; Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Dünkel A; Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Jansen JHM; Center for Translational Immunology, University Medical Center, Utrecht, The Netherlands.
  • Baumann N; Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Ten Broeke T; Center for Translational Immunology, University Medical Center, Utrecht, The Netherlands.
  • Nederend M; Center for Translational Immunology, University Medical Center, Utrecht, The Netherlands.
  • Eichholz K; Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Klausz K; Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Reiding K; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, and Netherlands Proteomics Center, Utrecht, The Netherlands.
  • Schewe DM; Pediatric Hematology/Oncology, Acute Lymphoblastic Leukemia--Berlin-Frankfurt-Münster Study Group, Christian-Albrechts-Universität and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany; and.
  • Kellner C; Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, LMU Munich, Munich, Germany.
  • Peipp M; Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
  • Leusen JHW; Center for Translational Immunology, University Medical Center, Utrecht, The Netherlands.
  • Valerius T; Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein Campus Kiel, Kiel, Germany.
Blood Adv ; 5(19): 3807-3820, 2021 10 12.
Article in En | MEDLINE | ID: mdl-34525171
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin A / Antigens, CD20 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Blood Adv Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoglobulin A / Antigens, CD20 Type of study: Prognostic_studies Limits: Humans Language: En Journal: Blood Adv Year: 2021 Document type: Article Affiliation country: Country of publication: